SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor targeting the SARS-CoV-2 3CL protease, demonstrating potent inhibitory activity with an IC50 of 4.9 µM. It is utilized in the research of coronavirus disease 2019 (COVID-19).
Molecular Weight:
405.36
Purity:
98.00%
CAS Number:
[302821-53-0]
Formula:
C22H15NO7
* VAT and and shipping costs not included. Errors and price changes excepted